• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Insiders Buying Hilton Worldwide And 2 Other Stocks

    5/30/24 7:16:25 AM ET
    $HLT
    $PRVA
    $WAT
    Hotels/Resorts
    Consumer Discretionary
    Medical/Nursing Services
    Health Care
    Get the next $HLT alert in real time by email

    Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.

    When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform.

    Privia Health Group

    • The Trade: Privia Health Group, Inc. (NASDAQ:PRVA) Director Adam Boehler acquired a total of 4,280 shares at an average price of $16.49. To acquire these shares, it cost around $70,577.
    • What's Happening: On May 20, Barclays analyst Andrew Mok maintained Privia Health with an Equal-Weight and lowered the price target from $22 to $19.
    • What Privia Health Group Does: Privia Health Group Inc is a technology-driven, national physician-enablement company.

    Hilton Worldwide

    • The Trade: Hilton Worldwide Holdings Inc. (NYSE:HLT) Director Melanie Healey acquired a total of 2,000 shares at an average price of $199.65. To acquire these shares, it cost around $399,299.
    • What's Happening: On April 24, Hilton Worldwide reported better-than-expected first-quarter financial results and raised FY24 adjusted EPS guidance.
    • What Hilton Worldwide Does: Hilton Worldwide Holdings operates nearly 1.2 million rooms across its more than 20 brands serving the premium economy scale through luxury segments.

    Don’t forget to check out our premarket coverage here

    Waters Corporation

    • The Trade: Waters Corporation (NYSE:WAT) Director Richard H Fearon bought a total of 1,000 shares at an average price of $332.90. To acquire these shares, it cost around $332,900.
    • What's Happening: On May 7, Waters Corp reported fiscal first-quarter 2024 sales of $636.8 million, beating the analyst consensus of $635.6 million.
    • What Waters Corporation Does: Water sells liquid chromatography, mass spectrometry, and thermal analysis tools.

    Read More: Top 3 Tech And Telecom Stocks That Could Blast Off This Quarter

    Get the next $HLT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLT
    $PRVA
    $WAT

    CompanyDatePrice TargetRatingAnalyst
    Waters Corporation
    $WAT
    2/10/2026$360.00In-line
    Evercore ISI
    Waters Corporation
    $WAT
    2/10/2026$425.00Buy
    Citigroup
    Waters Corporation
    $WAT
    2/10/2026$400.00Overweight
    Barclays
    Privia Health Group Inc.
    $PRVA
    1/9/2026$31.00Outperform
    RBC Capital Mkts
    Waters Corporation
    $WAT
    1/6/2026$440.00Buy
    Guggenheim
    Waters Corporation
    $WAT
    1/5/2026Outperform
    William Blair
    Hilton Worldwide Holdings Inc.
    $HLT
    12/15/2025$317.00Neutral → Buy
    Goldman
    Waters Corporation
    $WAT
    12/10/2025$480.00Peer Perform → Outperform
    Wolfe Research
    More analyst ratings

    $HLT
    $PRVA
    $WAT
    SEC Filings

    View All

    SEC Form 144 filed by Hilton Worldwide Holdings Inc.

    144 - Hilton Worldwide Holdings Inc. (0001585689) (Subject)

    2/17/26 3:08:29 PM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    SEC Form 10-K filed by Hilton Worldwide Holdings Inc.

    10-K - Hilton Worldwide Holdings Inc. (0001585689) (Filer)

    2/11/26 10:04:53 AM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    Hilton Worldwide Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Hilton Worldwide Holdings Inc. (0001585689) (Filer)

    2/11/26 6:01:15 AM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    $HLT
    $PRVA
    $WAT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Nassetta Christopher J exercised 114,289 shares at a strike of $41.41 and sold $36,283,559 worth of shares (114,289 units at $317.47) (SEC Form 4)

    4 - Hilton Worldwide Holdings Inc. (0001585689) (Issuer)

    2/19/26 6:06:02 PM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    New insider Fraser Claire claimed ownership of 131 shares (SEC Form 3)

    3 - WATERS CORP /DE/ (0001000697) (Issuer)

    2/18/26 4:15:11 PM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SVP, Waters Division Carpio Robert L Iii covered exercise/tax liability with 38 shares, decreasing direct ownership by 1% to 2,618 units (SEC Form 4)

    4 - WATERS CORP /DE/ (0001000697) (Issuer)

    2/6/26 7:34:54 PM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $HLT
    $PRVA
    $WAT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI resumed coverage on Waters with a new price target

    Evercore ISI resumed coverage of Waters with a rating of In-line and set a new price target of $360.00

    2/10/26 8:10:12 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Barclays resumed coverage on Waters with a new price target

    Barclays resumed coverage of Waters with a rating of Overweight and set a new price target of $400.00

    2/10/26 8:03:00 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Citigroup resumed coverage on Waters with a new price target

    Citigroup resumed coverage of Waters with a rating of Buy and set a new price target of $425.00

    2/10/26 8:03:00 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $HLT
    $PRVA
    $WAT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

    Headlines:Delivers up to 2× higher sensitivity than stainless steel microflow columns, lowering detection and quantitation limits across high-throughput bioseparations, DMPK, and 'omics applications.1 Uses up to 75% less sample than 2.1 mm I.D. columns, conserving precious materials such as cell and gene therapy and personalized medicine candidates while delivering deeper insights. 2 Reduces solvent consumption by up to 4× versus 2.1 mm I.D. columns, helping laboratories meet sustainability goals, lower operating costs, and accelerate time to results without compromising performance. 2 MILFORD, Mass., Feb. 17, 2026 /CNW/ -- Waters Corporation (NYSE:WAT) today launched 1 mm I.D. liquid chroma

    2/17/26 8:00:00 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Hilton Reports Fourth Quarter and Full Year Results

    Hilton Worldwide Holdings Inc. ("Hilton," "the Company," "we," "us" or "our") (NYSE:HLT) today reported its fourth quarter and full year 2025 results. Highlights include: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211262243/en/ Diluted EPS was $1.27 for the fourth quarter and $6.12 for the full year Diluted EPS, adjusted for special items, was $2.08 for the fourth quarter and $8.11 for the full year Net income was $298 million for the fourth quarter and $1,461 million for the full year Adjusted EBITDA was $946 million for the fourth quarter and $3,725 million for the full year System-wide comparable RevPAR in

    2/11/26 6:00:00 AM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

    Announces appointment of Claire M. Fraser, Ph.D., to its Board of DirectorsForms a global life sciences and diagnostics leader focused on high-volume testing in regulated applicationsAnnounces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials SciencesMILFORD, Mass., Feb. 9, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) ("Waters") today announced it has completed the previously announced combination with the Biosciences & Diagnostic Solutions businesses of Becton, Dickinson and Company (NYSE:BDX) ("BD"). The transaction forms a global life sciences and diagnostics leader, equipped with best-in-class technologies

    2/9/26 8:40:00 AM ET
    $BDX
    $WAT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $HLT
    $PRVA
    $WAT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mabus Raymond E bought $10,462 worth of shares (53 units at $197.39) and was granted 7 shares, increasing direct ownership by 0.42% to 14,456 units (SEC Form 4)

    4 - Hilton Worldwide Holdings Inc. (0001585689) (Issuer)

    7/1/25 5:09:24 PM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    Director Mchale Judith bought $1,001,361 worth of shares (4,750 units at $210.81), increasing direct ownership by 22% to 26,175 units (SEC Form 4)

    4 - Hilton Worldwide Holdings Inc. (0001585689) (Issuer)

    9/11/24 4:22:11 PM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    Director Boehler Adam bought $6,006 worth of shares (364 units at $16.50) (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    6/13/24 4:05:22 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $HLT
    $PRVA
    $WAT
    Financials

    Live finance-specific insights

    View All

    Hilton Reports Fourth Quarter and Full Year Results

    Hilton Worldwide Holdings Inc. ("Hilton," "the Company," "we," "us" or "our") (NYSE:HLT) today reported its fourth quarter and full year 2025 results. Highlights include: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211262243/en/ Diluted EPS was $1.27 for the fourth quarter and $6.12 for the full year Diluted EPS, adjusted for special items, was $2.08 for the fourth quarter and $8.11 for the full year Net income was $298 million for the fourth quarter and $1,461 million for the full year Adjusted EBITDA was $946 million for the fourth quarter and $3,725 million for the full year System-wide comparable RevPAR in

    2/11/26 6:00:00 AM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results

    Highlights Fourth Quarter 2025 Sales of $932 million landed at the high-end of reported sales growth guidance range; grew 7% as reported and 6% in constant currencyGrowth led by high single-digit constant currency growth in Pharma and Industrial end-markets, with broad-based growth across all regionsChemistry grew 12% in constant currency as new bioseparations products continued to experience significant customer demandInstruments grew 3% in constant currency, with high single-digit LC-MS growth partially offset by TA and transition to subscription model for EmpowerGAAP EPS of $3.77; non-GAAP EPS of $4.53 grew double digitsFull-Year 2025 Sales of $3,165 million grew 7% as reported and 7% in

    2/9/26 6:30:00 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

    Waters Corporation's Q4 2025 Financial Results Conference Call will now be held on Monday, February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass., Jan. 27, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) (the "Company" or "Waters") today announced that, at the Company's Special Meeting of Shareholders (the "Special Meeting") held today, Waters shareholders overwhelmingly voted to approve the issuance of shares of Waters common stock to shareholders of Becton, Dickinson and Company (NYSE:BDX) ("BD") in connection with the proposed combination of BD's Biosciences & Diagnostic Solutions business with Waters. 

    1/27/26 9:25:00 AM ET
    $BDX
    $WAT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $HLT
    $PRVA
    $WAT
    Leadership Updates

    Live Leadership Updates

    View All

    Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

    Announces appointment of Claire M. Fraser, Ph.D., to its Board of DirectorsForms a global life sciences and diagnostics leader focused on high-volume testing in regulated applicationsAnnounces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials SciencesMILFORD, Mass., Feb. 9, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) ("Waters") today announced it has completed the previously announced combination with the Biosciences & Diagnostic Solutions businesses of Becton, Dickinson and Company (NYSE:BDX) ("BD"). The transaction forms a global life sciences and diagnostics leader, equipped with best-in-class technologies

    2/9/26 8:40:00 AM ET
    $BDX
    $WAT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Hilton Delivers Strong 6.7% Net Unit Growth in 2025, Closes Year with Record 520,000 Rooms Under Development

    Hilton continues to have more rooms under construction than any other hotel company with approximately one in five rooms under construction globally slated to join the company's portfolio Hilton marked another remarkable year of growth in 2025, adding nearly 800 hotels and 100,000 new rooms to its global portfolio, representing full-year net unit growth of 6.7%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126116177/en/ACME Hotel Chicago Outset Collection by Hilton (Photo: Hilton) Owner appetite for Hilton's brands, increased conversion activity and outsized demand for luxury and lifestyle products continued to drive stro

    1/26/26 8:00:00 AM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    Hilton and Explora Journeys Announce Luxury Ocean Travel Partnership with Debut of Hilton Honors Adventures

    This partnership invites Hilton Honors members to enjoy Explora Journeys' modern vision of ultra elegant ocean travel defined by spacious suites, curated dining, and transformative Journeys. Explora Journeys is the new luxury ocean travel brand of the MSC Group with two ships currently sailing and a fleet of six ships by 2028. By summer 2026, Hilton Honors members will be able to earn and redeem Points on luxury ocean travel experiences through a new partnership with Explora Journeys. Limited-time preview offer gives Hilton Honors members the opportunity to book Explora Journeys with exclusive benefits that reflect the spirit of this new partnership, ahead of the ability to earn and

    12/8/25 8:01:00 AM ET
    $HLT
    Hotels/Resorts
    Consumer Discretionary

    $HLT
    $PRVA
    $WAT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

    SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

    11/14/24 5:20:21 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Waters Corporation

    SC 13G/A - WATERS CORP /DE/ (0001000697) (Subject)

    11/12/24 11:54:03 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

    SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

    11/12/24 10:34:17 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care